Related Experiment Video
Updated: Mar 13, 2026

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
Paravalvular Leaks: One Size (or Shape) Doesn't Always Fit All?
Andre Paixao1,2, Mehmet Cilingiroglu3,4
1Interventional Cardiology/Structural Heart Disease, Arkansas Heart Hospital, Little Rock, AR, USA.
Paravalvular leak (PVL) is a rare but serious complication following prosthetic valve surgery. Percutaneous treatment is often needed for PVL associated with heart failure or other severe conditions, but lacks dedicated devices.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Biomedical Engineering
Background:
- Paravalvular leak (PVL) is an uncommon yet serious complication after surgical prosthetic valve implantation.
- PVL can lead to severe conditions such as congestive heart failure, hemolytic anemia, and infective endocarditis.
- Patients requiring treatment for PVL often have high surgical risk, complicating management.
Purpose of the Study:
- To highlight the challenges in managing paravalvular leaks (PVL) after prosthetic valve surgery.
- To underscore the need for effective percutaneous treatment options for high-risk patients.
- To identify the limitations posed by the lack of dedicated PVL devices.
Main Methods:
- Review of clinical data for patients with paravalvular leak.
- Analysis of treatment outcomes for percutaneous interventions.
- Evaluation of device availability and suitability for PVL repair.
Main Results:
- Paravalvular leak is a significant complication associated with prosthetic valve surgery.
- Congestive heart failure, hemolytic anemia, and infective endocarditis are common sequelae of PVL.
- High surgical risk in the PVL patient population necessitates alternative treatment strategies.
- The absence of dedicated devices for PVL repair limits optimal percutaneous treatment options.
Conclusions:
- Paravalvular leak management is challenging due to patient comorbidities and lack of specialized devices.
- Percutaneous treatment is a viable option for high-risk patients but requires further device development.
- Further research and innovation in dedicated PVL devices are crucial for improving patient outcomes.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Aortic Regurgitation I: Introduction
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiovascular System Abnormal Findings II: Auscultation
Abnormal Heart Sounds
Gallops:

